Removal of serological interference in the treatment of multiple myeloma with CD38 monoclonal antibody using polybrene method / 中国输血杂志

【Objective】 To investigate the clinical feasibility of polybrene method to remove serological interference in patients receiving anti-CD38 monoclonal antibody for the treatment of multiple myeloma, and its detection performance of alloantibodies. 【Methods】 For patients receiving anti-CD38 monoclonal antibody for the treatment of multiple myeloma, unexpected antibody screening and cross-matching blood test were performed by polybrene method. 【Results】 The polybrene method can remove the interference of anti-CD38 monoclonal antibodies on blood group serology; both methods can effectively remove anti-CD38 monoclonal antibody to detect anti-E, anti-D, anti-Fya and anti-S antibodies.The titers of anti-D, anti-E, anti-Fya and anti-S alloantibodies, yielded by enhanced polybrene method, were higher than those of the polybrene method.Seven patients received K-antigen-negative blood transfusion without any adverse reactions to blood transfusion. 【Conclusion】 For the treatment of multiple myeloma using CD38 monoclonal antibody, the polybrene method can quickly and effectively remove the interference of daratumumab with blood group serology.

Daratumomab interference with pre-transfusion examination of patients with multiple myeloma / 中国输血杂志

【Objective】 To solve daratumomab interference with blood compatibility testing in multiple myeloma (MM) patients treated by daratumomab(DARA). 【Methods】 The irregular antibodies screening before and after the DARA treatment, and the major side crossmatch via coombs' test and polybrene method, respectively, were performed to resolve the nonspecific interference in a MM patient’s cross-matching test, produce by DARA. 【Results】 The initial panreactivity on the major side with agglutination (3+ ~4+ ), produce by DARA, was overcome by dithiothreitol (DTT) treatment, and turner out to be none agglutination. Otherwise, DARA had no effect on the crossmatch using polybrene method. 【Conclusion】 Antibody screening and identification should be conducted before DARA treatment in MM patients, and DARA interference with blood compatibility testing can be resolved by DTT treatment or the crossmatch using polybrene method.

Estudio de la desialización producida por larvas musculares de Trichinella spiralis / Desialylation study produced by muscle larvae of Trichinella spiralis

Trichinella spiralis es agente causal de una zoonosis endémica en Argentina. El objetivo fue estudiar la desialización eritrocitaria producida por larvas musculares (LM) de T. spiralis. Se trabajó con concentrados de LM, incubados en partes iguales con glóbulos rojos (GR) Grupo O (37 °C) durante 3 horas (con y sin agitación controlada) durante 150 minutos, a intervalos de 30 minutos, para estudiar el curso de la desialización en el tiempo. Los GR controles fueron incubados de la misma manera, con igual volumen de solución fisiológica. Se aplicó el método de titulación de la agregación, calculando título y coeficiente de puntuación total (CexpST). Se encontró que los eritrocitos incubados con LM presentaron mayor agregación que los controles. El valor medio de CexpST con agitación (0,43) fue significativamente menor que cuando los GR no se agitaron (0,72). El estudio de la desialización eritrocitaria en el tiempo mostró que el título de los GR control disminuyó significativamente a los 90 minutos en 5/10 repeticiones y a los 150 minutos en 9/10. El aumento del tiempo de incubación produjo el incremento de la desialización excepto a los 120 y 150 minutos donde no existieron diferencias significativas en el valor de CexpST. La experiencia realizada in vitro, sugeriría que en la infección in vivo, las LM podrían captar el ácido siálico a partir de los residuos sializados presentes en la célula muscular.

Trichinella spiralis is the cause of an endemic zoonosis in Argentina. The objective was to study the erythrocyte desialylation by T. spiralis muscle larvae (ML) applying an aggregation titulation method. We worked with ML concentrates, which were incubated with an equal volume of O Group erythrocytes (RBCs) at 37° C for 3 hours, (with and without controlled agitation) and for 150 minutes, taking samples at 30 minutes intervals to study the course in time of the desialylation. RBCs control were incubated with an equal volume of physiological saline solution. Aggregation titulation method was applied and the title and total score coefficient (TSexpC) were calculated. The results showed that erythrocytes incubated with ML showed more aggregation than controls. The average TSexpC with agitation (0.43) was significantly lower than when erythrocytes were not stirred (0.72). The course in time of the erythrocyte desialylation showed that the RBCs contol title decreased significantly at 90 minutes in 5/10 repetitions and at 150 minutes in 9/10. Increasing the incubation time produced an increase in erythrocyte desialylation, except at the 120 and 150 minutes interval where no significant differences in TSexpC values were found. The in vitro experience would suggest that in cases of in vivo infection, ML could capture sialic acid from sialylate residues present in the muscle cell.